Neuland Laboratories Limited (BOM:524558)
13,026
+56 (0.43%)
At close: Mar 6, 2026
Neuland Laboratories Market Cap
Neuland Laboratories has a market cap or net worth of 167.12 billion as of March 6, 2026. Its market cap has increased by 2.55% in one year.
Market Cap
167.12B
Enterprise Value
168.08B
Revenue
15.75B
Ranking
n/a
PE Ratio
93.29
Stock Price
13,025.90
Market Cap Chart
Since December 18, 2000, Neuland Laboratories's market cap has increased from 335.14M to 167.12B, an increase of 49,766.05%. That is a compound annual growth rate of 27.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 167.12B | -14.25% |
| Dec 31, 2025 | 194.89B | 10.65% |
| Dec 31, 2024 | 176.13B | 159.63% |
| Dec 29, 2023 | 67.84B | 216.90% |
| Dec 30, 2022 | 21.41B | 7.77% |
| Dec 31, 2021 | 19.86B | 41.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sudeep Pharma | 65.88B |
| Shilpa Medicare | 65.01B |
| Gujarat Themis Biosyn | 32.34B |
| Suven Life Sciences | 32.03B |
| IOL Chemicals and Pharmaceuticals | 21.74B |
| NGL Fine-Chem | 14.85B |
| Bajaj HealthCare | 10.03B |
| Shree Ganesh Remedies | 6.36B |